Literature DB >> 28536724

Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment.

Bo Young Kim1, Hyun-Sook Kim2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28536724      PMCID： PMC5435848          DOI： 10.11622/smedj.2017039

Source DB:  PubMed          Journal:  Singapore Med J        ISSN： 0037-5675            Impact factor:   1.858


× No keyword cloud information.
  9 in total

1.  Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis.

Authors:  Arjun Dhayalan; Brett A King
Journal:  JAMA Dermatol       Date:  2016-04       Impact factor: 10.282

2.  Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.

Authors:  Luzhou Xing; Zhenpeng Dai; Ali Jabbari; Jane E Cerise; Claire A Higgins; Weijuan Gong; Annemieke de Jong; Sivan Harel; Gina M DeStefano; Lisa Rothman; Pallavi Singh; Lynn Petukhova; Julian Mackay-Wiggan; Angela M Christiano; Raphael Clynes
Journal:  Nat Med       Date:  2014-08-17       Impact factor: 53.440

3.  Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.

Authors:  Lynn Petukhova; Madeleine Duvic; Maria Hordinsky; David Norris; Vera Price; Yutaka Shimomura; Hyunmi Kim; Pallavi Singh; Annette Lee; Wei V Chen; Katja C Meyer; Ralf Paus; Colin A B Jahoda; Christopher I Amos; Peter K Gregersen; Angela M Christiano
Journal:  Nature       Date:  2010-07-01       Impact factor: 49.962

4.  Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis.

Authors:  Brittany G Craiglow; Brett A King
Journal:  J Invest Dermatol       Date:  2014-06-18       Impact factor: 8.551

5.  Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.

Authors:  Ali Jabbari; Nhan Nguyen; Jane E Cerise; Grace Ulerio; Annemieke de Jong; Raphael Clynes; Angela M Christiano; Julian Mackay-Wiggan
Journal:  Exp Dermatol       Date:  2016-08       Impact factor: 3.960

6.  Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci.

Authors:  Regina C Betz; Lynn Petukhova; Stephan Ripke; Hailiang Huang; Androniki Menelaou; Silke Redler; Tim Becker; Stefanie Heilmann; Tarek Yamany; Madeliene Duvic; Maria Hordinsky; David Norris; Vera H Price; Julian Mackay-Wiggan; Annemieke de Jong; Gina M DeStefano; Susanne Moebus; Markus Böhm; Ulrike Blume-Peytavi; Hans Wolff; Gerhard Lutz; Roland Kruse; Li Bian; Christopher I Amos; Annette Lee; Peter K Gregersen; Bettina Blaumeiser; David Altshuler; Raphael Clynes; Paul I W de Bakker; Markus M Nöthen; Mark J Daly; Angela M Christiano
Journal:  Nat Commun       Date:  2015-01-22       Impact factor: 14.919

7.  Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib.

Authors:  Ali Jabbari; Zhenpeng Dai; Luzhou Xing; Jane E Cerise; Yuval Ramot; Yackov Berkun; Gina A Montealegre Sanchez; Raphaela Goldbach-Mansky; Angela M Christiano; Raphael Clynes; Abraham Zlotogorski
Journal:  EBioMedicine       Date:  2015-02-26       Impact factor: 8.143

8.  Alopecia universalis during treatment with leflunomide and adalimumab - case report.

Authors:  Rosana Lazzarini; Gabriela Cunha Capareli; Roberta Buense; Rute Facchini Lellis
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

9.  Transient Efficacy of Tofacitinib in Alopecia Areata Universalis.

Authors:  Florian Anzengruber; Julia-Tatjana Maul; Jivko Kamarachev; Ralph M Trüeb; Lars E French; Alexander A Navarini
Journal:  Case Rep Dermatol       Date:  2016-04-22
  9 in total
  2 in total

Review 1.  Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata.

Authors:  Ana M Montilla; Francisco Gómez-García; Pedro J Gómez-Arias; Jesús Gay-Mimbrera; Jorge Hernández-Parada; Beatriz Isla-Tejera; Juan Ruano
Journal:  Dermatol Ther (Heidelb)       Date:  2019-10-13

Review 2.  Role of janus kinase inhibitors in the treatment of alopecia areata.

Authors:  Korn Triyangkulsri; Poonkiat Suchonwanit
Journal:  Drug Des Devel Ther       Date:  2018-07-27       Impact factor: 4.162
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.